Risk Perception and Acceptability of the COVID-19 Vaccine in Nigeria

5Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Objectives: Vaccines are anticipated to control the ongoing coronavirus disease-2019 (COVID-19) pandemic, however, their acceptance is critical for the desired benefit. This study assessed risk perceptions of COVID-19, acceptability of its vaccine and socio-demographic associations of its acceptability in Nigeria. Materials and Methods: A cross-sectional web-based study was conducted among 420 participants in Nigeria’s six geopolitical regions, using a three-part questionnaire. The questionnaire link was distributed via snowball method to consenting participants through online platforms. Study outcome measures were acceptance of COVID-19 vaccine, and risk perception of COVID-19 by study participants. Descriptive and inferential statistics were performed using Microsoft Excel and SPSS version 24. p values ≤0.05 were considered statistically significant. Results: A total of 410 respondents participated in the study and high-risk perception of severe acute respiratory syndrome-coronavirus-2 infection (COVID-19) was seen in 127 (66.1%) respondents. Vaccine acceptance was high in 233 (56.8%) respondents and was significantly associated with geo-political region (p=0.028). A moderate positive relationship (r: 0.3) was found between risk perception and acceptability of COVID-19 vaccine and the correlation was statistically significant (p=0.000). Conclusion: High-risk perception of COVID-19 was found in over half of the respondents, and COVID-19 vaccine acceptance rate was a little more than 50%. However, the study noted regional association with vaccine acceptance among study participants. Therefore, strategic and targeted messaging on vaccine acceptance should be prioritized by stakeholders, to ensure successful vaccine implementation.

Cite

CITATION STYLE

APA

Iheanacho, C. O., Enechukwu, O. H., & Aguiyi-Ikeanyi, C. N. (2022). Risk Perception and Acceptability of the COVID-19 Vaccine in Nigeria. Turkish Journal of Pharmaceutical Sciences, 19(6), 686–693. https://doi.org/10.4274/tjps.galenos.2021.75710

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free